| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,420 | 13,081 | ||
| Tax incentive and other receivables | 1,991 | 1,323 | ||
| Prepaid expenses and other assets | 1,214 | 966 | ||
| Total current assets | 9,625 | 15,370 | ||
| Property and equipment, net | 7 | 8 | ||
| Intangible assets, net | 2,571 | - | ||
| Other assets | 240 | 244 | ||
| Total assets | 12,443 | 15,622 | ||
| Accounts payable | 5,105 | 4,759 | ||
| Accrued expenses and other liabilities | 2,782 | 2,593 | ||
| Total current liabilities | 7,887 | 7,352 | ||
| Warrant liabilities | 11 | 8 | ||
| Total liabilities | 7,898 | 7,360 | ||
| Common stock, 0.01 par value, 250,000,000 shares authorized, 7,131,151 and 3,650,731 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 71 | 71 | ||
| Additional paid-in capital | 637,009 | 636,761 | ||
| Accumulated deficit | -632,541 | -628,579 | ||
| Accumulated other comprehensive income (loss) | 6 | 9 | ||
| Total stockholders' equity (deficit) | 4,545 | 8,262 | ||
| Total liabilities and stockholders' equity (deficit) | 12,443 | 15,622 | ||
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW)